Gender, variation in opioid receptor genes and sensitivity to experimental pain

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Sato, Hiroe ^a   Droney, Joanne ^a,b   Ross, Joy ^a,b   Olesen, Anne Estrup ^c   Staahl, Camilla ^c   Andresen, Trine ^c   Branford, Ruth ^a,b   Riley, Julia ^b   Arendt Nielsen, Lars ^d   Drewes, Asbjørn Mohr ^c,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Gender; Opioid receptor genes; OPRD; OPRK; OPRM; Pain tolerance thresholds

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

ADULT; ARTICLE; DELTA OPIATE RECEPTOR GENE; EXON; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; INTRON; KAPPA OPIATE RECEPTOR GENE; MALE; MU OPIATE RECEPTOR GENE; MYALGIA; NOCICEPTION; NORMAL HUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN PAIN; VISCERAL PAIN;

ADULT; AGING; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLES; PAIN; PAIN THRESHOLD; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID; REGRESSION ANALYSIS; SEX CHARACTERISTICS; VISCERA; YOUNG ADULT;

EID: 84875909950     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-20     Document Type: Article

References (54)

1. Williams FM, Spector TD, MacGregor AJ. Pain reporting at different body sites is explained by a single underlying genetic factor. Rheumatology (Oxford) 2010, 49(9):1753-1755.
2. Livshits G, Popham M, Malkin I, Sambrook PN, MacGregor AJ, Spector T. Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study. Ann Rheum Dis 2011, 70(10):1740-1745. 10.1136/ard.2010.137836, 3171106, 21646416.
3. Hartvigsen J, Nielsen J, Kyvik KO, Fejer R, Vach W, Iachine I. Heritability of spinal pain and consequences of spinal pain: a comprehensive genetic epidemiologic analysis using a population-based sample of 15,328 twins ages 20-71 years. Arthritis Rheum 2009, 61(10):1343-1351. 10.1002/art.24607, 19790135.
4. Norbury TA, MacGregor AJ, Urwin J, Spector TD, McMahon SB. Heritability of responses to painful stimuli in women: a classical twin study. Brain 2007, 130(Pt 11):3041-3049.
5. Nielsen CS, Stubhaug A, Price DD, Vassend O, Czajkowski N, Harris JR. Individual differences in pain sensitivity: genetic and environmental contributions. Pain 2008, 136(1-2):21-29.
6. Gosso MF, Barrett CF, van den Maagdenberg A, Ferrari MD. Pain-Related Mutations in the Human Genome. Pain 2010-An Updated Review 2010, Seattle: IASP Press, Mogil JS.
7. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444(7121):894-898. 10.1038/nature05413, 17167479.
8. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, Abrahamsen B. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006, 52(5):767-774. 10.1016/j.neuron.2006.10.006, 17145499.
9. Lotsch J, Geisslinger G. A critical appraisal of human genotyping for pain therapy. Trends Pharmacol Sci 2010, 31(7):312-317. 10.1016/j.tips.2010.04.002, 20483491.
10. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D. Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 2009, 137(6):1148-1159. 10.1016/j.cell.2009.04.019, 19524516.
11. Huang CJ, Liu HF, Su NY, Hsu YW, Yang CH, Chen CC. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*. Anaesthesia 2008, 63(12):1288-1295. 10.1111/j.1365-2044.2008.05760.x, 19032295.
12. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 2005, 6(3):159-167. 10.1016/j.jpain.2004.11.008, 15772909.
13. Lau H, Patil NG. Acute pain after endoscopic totally extraperitoneal (TEP) inguinal hernioplasty: multivariate analysis of predictive factors. Surg Endosc 2004, 18(1):92-96. 10.1007/s00464-003-9068-y, 14625741.
14. NCBI HapMap frequency data on SNP databbase, NCBI (National Centre for Biotechnology Information) 2009, NCBI, [cited 2009 Jun 20];Available from: URL: www.ncbi.nlm.nih.gov, NCBI.
15. Walter C, Lotsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain 2009, 146(3):270-275. Dec, 10.1016/j.pain.2009.07.013, 19683391.
16. Kim H, Neubert JK, San Miguel A, Xu K, Krishnaraju RK, Iadarola MJ. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain 2004, 109(3):488-496. 10.1016/j.pain.2004.02.027, 15157710.
17. Kim H, Mittal DP, Iadarola MJ, Dionne RA. Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet 2006, 43(8):e40. 10.1136/jmg.2005.036079, 2564596, 16882734.
18. Bergeson SE, Helms ML, O'Toole LA, Jarvis MW, Hain HS, Mogil JS. Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome 2001, 12(7):546-553. 10.1007/s003350020022, 11420618.
19. Martin M, Matifas A, Maldonado R, Kieffer BL. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur J Neurosci 2003, 17(4):701-708. 10.1046/j.1460-9568.2003.02482.x, 12603260.
20. Gaveriaux-Ruff C, Kieffer BL. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 2002, 36(2-3):62-71.
21. Nadal X, Banos JE, Kieffer BL, Maldonado R. Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci 2006, 23(3):830-834. 10.1111/j.1460-9568.2006.04569.x, 16487163.
22. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 1998, 17(4):886-897. 10.1093/emboj/17.4.886, 1170438, 9463367.
23. Park PS, Palczewski K. Diversifying the repertoire of G protein-coupled receptors through oligomerization. Proc Natl Acad Sci USA 2005, 102(25):8793-8794. 10.1073/pnas.0504016102, 1157063, 15956197.
24. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 2004, 101(14):5135-5139. 10.1073/pnas.0307601101, 387386, 15044695.
25. Droney JM, Gretton SK, Sato H, Ross JR, Branford R, Welsh KI. Analgesia and central side-effects: two separate dimensions of morphine response. Br J Clin Pharmacol 2012, Epub ahead of print.
26. Zondervan KT, Cardon LR. The complex interplay among factors that influence allelic association. Nat Rev Genet 2004, 5(2):89-100.
27. Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 2005, 133(1):209-220. 10.1016/j.neuroscience.2004.12.033, 15893644.
28. Pan YX. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 2005, 24(11):736-750. 10.1089/dna.2005.24.736, 16274294.
29. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K. Expansion of the Human {micro}-Opioid Receptor Gene Architecture: Novel Functional Variants. Hum Mol Genet 2009, 18(6):1037-1051. Mar 15, 10.1093/hmg/ddn439, 2649019, 19103668.
30. Gaveriaux-Ruff C, Peluso J, Befort K, Simonin F, Zilliox C, Kieffer BL. Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta- and kappa-opioid receptors. Brain Res Mol Brain Res 1997, 48(2):298-304. 10.1016/S0169-328X(97)00109-5, 9332727.
31. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W. Genetic architecture of human pain perception. Trends Genet 2007, 23(12):605-613. 10.1016/j.tig.2007.09.004, 18023497.
32. Pedersen J, Reddy H, Funch-Jensen P, Arendt-Nielsen L, Gregersen H, Drewes AM. Differences between male and female responses to painful thermal and mechanical stimulation of the human esophagus. Dig Dis Sci 2004, 49(7-8):1065-1074.
33. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009, 10(5):447-485. 10.1016/j.jpain.2008.12.001, 2677686, 19411059.
34. Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology 2009, 111(3):657-677. 10.1097/ALN.0b013e3181aae87a, 19672167.
35. Millan MJ. Descending control of pain. Prog Neurobiol 2002, 66(6):355-474. 10.1016/S0301-0082(02)00009-6, 12034378.
36. Paine P, Worthen SF, Gregory LJ, Thompson DG, Aziz Q. Personality differences affect brainstem autonomic responses to visceral pain. Neurogastroenterol Motil 2009, 21(11):1155-e1198. 10.1111/j.1365-2982.2009.01348.x, 19538443.
37. Paine P, Kishor J, Worthen SF, Gregory LJ, Aziz Q. Exploring relationships for visceral and somatic pain with autonomic control and personality. Pain 2009, 144(3):236-244. 10.1016/j.pain.2009.02.022, 19398272.
38. Coen SJ, Kano M, Farmer AD, Kumari V, Giampietro V, Brammer M. Neuroticism influences brain activity during the experience of visceral pain. Gastroenterology 2011, 141(3):909-917. 10.1053/j.gastro.2011.06.008, 21699797.
39. Knudsen AK, Brunelli C, Kaasa S, Apolone G, Corli O, Montanari M. Which variables are associated with pain intensity and treatment response in advanced cancer patients? - Implications for a future classification system for cancer pain. Eur J Pain 2011, 15(3):320-327. Mar, 10.1016/j.ejpain.2010.08.001, 20822941.
40. Dworkin BR, Filewich RJ, Miller NE, Craigmyle N, Pickering TG. Baroreceptor activation reduces reactivity to noxious stimulation: implications for hypertension. Science 1979, 205(4412):1299-1301. 10.1126/science.472749, 472749.
41. Neziri AY, Curatolo M, Nuesch E, Scaramozzino P, Andersen OK, Arendt-Nielsen L. Factor analysis of responses to thermal, electrical, and mechanical painful stimuli supports the importance of multi-modal pain assessment. Pain 2011, 152(5):1146-1155. 10.1016/j.pain.2011.01.047, 21396782.
42. Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004, 22(8):1382-1388. 10.1200/JCO.2004.07.173, 15007088.
43. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308(5720):385-389. 10.1126/science.1109557, 1512523, 15761122.
44. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314(5801):989-992. 10.1126/science.1133807, 17053108.
45. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005, 6(2):95-108.
46. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005, 6(2):109-118. 10.1038/nrg1522, 15716907.
47. Olesen AE, Staahl C, rendt-Nielsen L, Drewes AM. Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study. Br J Clin Pharmacol 2010, 70(2):189-200. 10.1111/j.1365-2125.2010.03700.x, 2911549, 20653672.
48. Arendt-Nielsen L, Curatolo M, Drewes A. Human experimental pain models in drug development: translational pain research. Curr Opin Investig Drugs 2007, 8(1):41-53.
49. Staahl C, Christrup LL, Andersen SD, Arendt-Nielsen L, Drewes AM. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain 2006, 123(1-2):28-36.
50. Arendt-Nielsen L, Olesen AE, Staahl C, Menzaghi F, Kell S, Wong GY. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain. Anesthesiology 2009, 111(3):616-624. 10.1097/ALN.0b013e3181af6356, 19672186.
51. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68(4):978-989. 10.1086/319501, 1275651, 11254454.
52. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
53. Thornton-Wells TA, Moore JH, Haines JL. Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet 2004, 20(12):640-647. 10.1016/j.tig.2004.09.007, 15522460.
54. Mundform DJ, Perrett JJ, Schaffer J, Piccone A, Roozeboom. Bonferroni adjustments in tests for regression coefficients. Multiple Linear Regression Viewpoints 2006, 32(1):1-6.